Overview of the 84th Annual Scientific Meeting of the Japanese Circulation Society ― Change Practice! ―
Open Access
- 25 February 2021
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 85 (3), 323-329
- https://doi.org/10.1253/circj.cj-21-0041
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesThis publication has 10 references indexed in Scilit:
- Initial Invasive or Conservative Strategy for Stable Coronary DiseaseThe New England Journal of Medicine, 2020
- Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trialThe Lancet, 2019
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionThe New England Journal of Medicine, 2019
- Five-Year Outcomes after PCI or CABG for Left Main Coronary DiseaseThe New England Journal of Medicine, 2019
- Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary DiseaseThe New England Journal of Medicine, 2019
- Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trialThe Lancet, 2019
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIJAMA, 2019
- Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent ImplantationCirculation, 2019
- One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trialCardiovascular Intervention and Therapeutics, 2015
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureThe New England Journal of Medicine, 2014